OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 6.90
-0.29 (-4.03%)
May 21, 2026, 12:30 PM CET
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of 101.01 million as of May 21, 2026. Its market cap has increased by 92.70% in one year.
Market Cap
101.01M
Enterprise Value
104.79M
Revenue
2.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.90
Market Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has increased from 89.02M to 101.01M, an increase of 13.46%. That is a compound annual growth rate of 2.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 101.01M | 18.14% |
| Dec 30, 2025 | 85.49M | 94.64% |
| Dec 30, 2024 | 43.92M | 21.36% |
| Dec 29, 2023 | 36.19M | -43.82% |
| Dec 30, 2022 | 64.42M | -52.42% |
| Dec 30, 2021 | 135.41M | 52.11% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alligator Bioscience AB | 140.70M |
| Magle Chemoswed Holding AB | 119.55M |
| NextCell Pharma AB | 118.30M |
| IRLAB Therapeutics AB | 107.70M |
| Annexin Pharmaceuticals AB | 105.18M |
| AcouSort AB | 103.28M |
| Biovica International AB | 101.29M |
| Scandinavian ChemoTech AB | 92.91M |